ARCH Venture Fund XIV reports acquisition of $18 million in Aspen Neuroscience common shares
ASPE•ARCH Venture Partners XIV reported purchasing 1.2 million Aspen Neuroscience common shares at $15 each, for total beneficial ownership of 1.2 million shares.
1. Share purchase
A beneficial ownership filing reported that ARCH Venture Partners XIV purchased 1.2 million Aspen Neuroscience common shares at $15 each. The filing reported beneficial ownership of 1.2 million common shares following the purchase.
